Zaki Salanti

Scientific Advisor, Search & Evaluation at Novo Nordisk A/S

Speaker

Zaki Salanti is Scientific Advisor in Search and Evaluation, Global Business Development at Novo Nordisk. He was previously Director Toxicology at Novo Nordisk. Zaki joined Novo Nordisk in 2005.

Since 2018, Zaki has been involved in scouting and coordination of evaluation of external innovation in the cardiometabolic space. Besides innovative therapies, the Search and Evaluation team is leading assessment of a broad range of technologies, including new drug delivery systems and protein engineering.